MARKET

AMPH

AMPH

Amphastar Pharma
NASDAQ
28.50
+0.95
+3.45%
After Hours: 28.50 0 0.00% 16:10 02/13 EST
OPEN
27.82
PREV CLOSE
27.55
HIGH
29.00
LOW
27.76
VOLUME
268.69K
TURNOVER
--
52 WEEK HIGH
32.69
52 WEEK LOW
20.39
MARKET CAP
1.31B
P/E (TTM)
12.64
1D
5D
1M
3M
1Y
5Y
1D
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Mixed Returns And A 13.9% Undervaluation Narrative
Simply Wall St · 11h ago
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
Barchart · 14h ago
Weekly Report: what happened at AMPH last week (0202-0206)?
Weekly Report · 4d ago
Is Amphastar (AMPH) Turning Margin Compression Into a Test of Its Operational Discipline?
Simply Wall St · 02/06 02:18
Weekly Report: what happened at AMPH last week (0126-0130)?
Weekly Report · 02/02 10:01
Weekly Report: what happened at AMPH last week (0119-0123)?
Weekly Report · 01/26 10:01
Amphastar Pharmaceuticals (AMPH) Gets a Hold from Bank of America Securities
TipRanks · 01/20 11:56
Weekly Report: what happened at AMPH last week (0112-0116)?
Weekly Report · 01/19 10:05
More
About AMPH
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.

Webull offers Amphastar Pharmaceuticals Inc stock information, including NASDAQ: AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.